This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
-
Merck: La administración de Vioxx (F)
Simons, Robert L.; Kindred, NatalieCase HBS-111S07Knowledge and CommunicationStarting at €5.74
-
For-Profit Higher Education: University of Phoenix, Teaching Note
Yu, Gwen; Noe, Christopher F.; Weber, JosephTeaching Note HBS-114032-EAccounting and ControlTeaching Note for 114024.Starting at €0.00
-
For-Profit Higher Education: University of Phoenix
Yu, Gwen; Noe, Christopher F.; Weber, Joseph; McLellan, JudyCase HBS-114024-EAccounting and ControlStarting at €8.20
-
La educación superior con fines lucrativos: University of Phoenix
Yu, Gwen; Noe, Christopher F.; Weber, Joseph; McLellan, JudyCase HBS-116S05Accounting and ControlStarting at €8.20
-
Microsoft's aQuantive Acquisition
Yu, Gwen; Noe, Christopher F.; Weber, Joseph; Samuelson, ThomasCase HBS-115039-EAccounting and ControlThis case introduces students to the topic of mergers and acquisitions. At the time that Microsoft purchased aQuantive there was a mixed reaction by analysts and investors on whether this transaction would increase shareholder value. Ultimately the transaStarting at €8.20
-
Managing Vioxx (A) (Spanish version)
Simons, Robert L.; Rosenberg, Kathryn; Kindred, NatalieCase HBS-111S02Strategy(B) evidence of life-threatening side effects, (C) decision options, (D) announcement to withdraw Vioxx, (E) reaction by patients, shareholders, media, and regulators, (F) Merck fights back, and (G) wrap-up. At the end of the case series, students may conclude that doing the right thing sometimes requires very hard choices.Starting at €8.20